Transcriptomics

Dataset Information

0

Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF


ABSTRACT: While oncogenes can potentially be inhibited with small molecules, the loss of tumor suppressors is more common and presents a conundrum for precision therapy because the proteins are no longer present. SMARCB1-mutant cancers epitomize this challenge because these highly lethal cancers are driven by inactivation of a single gene, a subunit of SWI/SNF chromatin remodeling complexes. To generate mechanistic insight into the consequences of SMARCB1 mutation and to seek vulnerabilities, we contributed 16 SMARCB1-mutant cell lines to a near-genomewide CRISPR screen as part of the Cancer Dependency Map1-3. Here we report that the little-studied gene DCAF5 (DDB1-CUL4 Associated Factor 5) is a specific dependency in SMARCB1-mutant cancers. We show that DCAF5 serves a quality control function for SWI/SNF complexes and in the absence of SMARCB1 DCAF5 causes degradation of incompletely assembled SWI/SNF complexes. Upon inhibition of DCAF5 SMARCB1-deficient SWI/SNF complexes re-accumulate, bind to target loci, and restore gene expression to levels sufficient to fully reverse the cancer state, including in a xenograft mouse model. Consequently, cancer results not from the loss of SMARCB1 function per se but rather from DCAF5-mediated degradation of SWI/SNF complexes. These data indicate that therapeutic targeting of DCAF5 may be sufficient to restore substantial SWI/SNF function and reverse cancer phenotypes caused by SMARCB1 loss.

ORGANISM(S): Homo sapiens

PROVIDER: GSE215024 | GEO | 2024/03/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-03-22 | GSE215023 | GEO
2024-03-22 | GSE215022 | GEO
2024-01-21 | PXD046273 | Pride
2024-01-21 | PXD046275 | Pride
2024-01-21 | PXD046276 | Pride
| PRJNA866519 | ENA
2019-03-14 | GSE125775 | GEO
2019-03-14 | GSE120234 | GEO
2019-03-14 | GSE120233 | GEO
2020-12-02 | GSE147476 | GEO